Author Profile

Destiny Hinton

Destiny HInton

Destiny Hinton is a communications intern in the Department of Communications & Scientific and Medical Content Outreach at St. Jude Children’s Research Hospital.

Stories by Destiny Hinton

Avian flu
Avian flu
Research

St. Jude avian flu hunters’ annual data collection provides context for ongoing pandemic

Alex Generous, PhD

See how St. Jude collects avian influenza samples to stay a step ahead of the virus.

Heather Mefford
Heather Mefford
Investigator Insights

Creating Supportive Spaces in Science with Heather Mefford, MD, PhD

Heather Mefford, MD, PhD

Heather Mefford, MD, PhD, knows the importance of being part of a supportive and inclusive culture. Learn how she creates supportive spaces for scientists at St. Jude.

Drugging the genome
Drugging the genome
St. Jude On

The era of genome-targeted therapeutics

Aseem Ansari

Explore the different ways scientists at St. Jude are leveraging genomics to develop novel therapeutics.

St. Jude Cloud
St. Jude Cloud
Research

St. Jude Cloud visualizations empower scientist’s work

Alex Generous, PhD

One scientist’s experience making high quality visualization with the St. Jude Cloud.

Editing sickle cell illustration
Editing sickle cell illustration
St. Jude On

Gene editing holds the promise of a sickle cell cure

Alex Generous, PhD

Explore genome editing approaches to cure sickle cell disease.

STEMM careers
STEMM careers
Outreach

Bridging the Gap: Promoting diversity and inclusion in the next generation of STEMM leaders

Kate Ayers and Jennifer Stripay, PhD

The STEMM Education and Outreach team at St. Jude helps address barriers to careers in science.

St. Jude on Modifying Transcription
St. Jude on Modifying Transcription
St. Jude On

The road to drugging the undruggable

Brian O'Flynn, PhD

Explore research in the Shelat lab to drug the undruggable.

Molecular Pathway
Molecular Pathway
Clinical

SJiMB21: A molecular path to treating infants with medulloblastoma

Jessie Newman and Kathryn J. McCullough, MA

At St. Jude, clinical trial SJiMB21 seeks to provide treatment strategies for infants and young children diagnosed with medulloblastoma that place the patient, not just the tumor, at the center of care.

Targeting Epilepsy illustration
Targeting Epilepsy illustration
St. Jude On

Genomic underpinnings of epilepsy hold therapeutic clues

Helen Chen

Scientists are digging into the genomic causes of epilepsy disorders to learn how to treat them.

CureAll virtual backdrop
CureAll virtual backdrop
Outreach

Strategic discussions chart a path forward for St. Jude Global & WHO CureAll efforts

Lance Wiedower

St. Jude Global, WHO and colleagues around the world are working to raise the childhood cancer survival rate.